Gamma-Interferon Enhances the Cytotoxic Activity of Interleukin-2-Induced Peripheral Blood Lymphocyte (LAK) Cells, Tumor Infiltrating Lymphocytes (TIL), and Effusion Associated Lymphocytes

References

• Taniguchi T, Matsui H, Fugita T, Takoka C, Kashina, Yoshimoro R, Hamuro J. Structure and expression of a cloned cDNA for Human interleukin 2. Nature (Lond) 1983; 302: 305–307.
   Google Scholar
• Rosenberg SA. Lymphokine activated killer cells: A new approach to the immunotherapy of cancer. J Natl Cancer Inst 1985; 75: 595–603.
   Google Scholar
• Mazumder A, Rosenberg SA. Successful immunotherapy of natural lymphocytes activated in vitro by interleukin-2. J Exp Med 1984; 159: 495–507.
   Google Scholar
• Salup RR, Beck TC, Wiltrout RH. Successful treatment of advanced murine renal cell cancer by bi-compartmental adoptive chemoimmunotherapy. J Immunol 1987; 138: 641–647.
   Google Scholar
• Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–1492.
   Google Scholar
• Rosenberg SA, Lotze MT, Muul LM, et al. A progress report in the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin 2 alone. N Engl J Med 1987; 316: 889–897.
   Google Scholar
• West WH, Kurt TW, Yannell JR, et al. Constant infusion recombinant interleukin 2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987; 316: 898–905.
   Google Scholar
• Lander I, Aherne W. The significance of lymphocyte infiltration in neuroblastoma. Br J Cancer 1968; 3: 161–164.
   Google Scholar
• Bennett SH, Futrell JM, Roth J A, Hoye RC, Ketchamn AS. Prognostic significance of histologic host response in cancer of the larynx or hypopharynx. Cancer (Phila) 1971; 28: 1255–1265.
   Google Scholar
• Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ, Mihm MC. Major-histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol 1982; 129: 2808–2813.
   Google Scholar
• Yoo YK, Heo DS, Hata K, Van Thiel DH, Whiteside TL. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology 1990; 98: 259–268.
   Google Scholar
• Itoh K, Platsoukas CD, Balch CM. Autologous tumorspecific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 1988; 168: 1419–1441.
   Google Scholar
• Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy for cancer: Synergistic antitumor interactions of interleukin-2, alpha interferon, and tumor-infiltrating lymphocytes. Science 1986; 233: 1318–1321.
   Google Scholar
• Vose BM. Quantitation of proliferative and cytotoxic precursor cells directed against human tumors: Limiting dilution analysis in peripheral blood and at the tumor site. Int J Cancer 1982; 30: 135–142.
   Google Scholar
• Belldegrun A, Muul LM, Rosenberg SA. Interleukin 2 expanded tumor-infiltrating lymphocytes in human cell cancer: Isolation, characterization, and antitumor activity. Cancer Res 1988; 48: 206–214.
   Google Scholar
• Haskill S, Becker S, Fowler W. Mononuclear cell infiltration in ovarian cancer. I Inflammatory cell infiltrates from tumor and ascites material. Br J Cancer 1982; 45: 728–736.
   Google Scholar
• Blanchard DK, Kavanagh JJ, Sinkovics JG, Cavanagh D, Hewitt SM, Djeu JY. Infiltration of interleukin-2-induci-ble killer cells in ascitic fluid and pleural effusions of advanced cancer patients. Cancer Res 1988; 48: 6321–6327.
   Google Scholar
• Ioannides CG, Freedman RS. T cell responses to ovarian tumor vaccines: Identification and significance for future immunotherapy. Intern Rev Immunol 1991; 7: 349–364.
   Google Scholar
• Epstein LB. The specific significance of interferon gamma. In: Interferon, edited by J Vilcek, EE Maeyer, Amsterdam, Elsevier, 1984: 185–220.
   Google Scholar
• Gray PW, Goeddol DV. Cloning and expression of murine immune interferon cDNA. Proc Natl Acad Sci 1983; 80: 5842–5847.
   Google Scholar
• Wallach D, Fellons M, Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 1982; 299: 833–835.
   Google Scholar
• Basham TX, Merigan TC. Recombinant interferon gamma increases HLA-DR synthesis and expression. J Immunol 1982; 130: 1492–1497.
   Google Scholar
• Trinchieri G. Biology of the natural killer cells. Adv Immunol 1989; 47: 187–205.
   Google Scholar
• Itoh K, Tilden AB, Balch CM. Interleukin 2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res. 1986; 46: 3011–3017.
   Google Scholar
• Uchida A, Micksche M. Suppressor cells for natural killer activity in carcinomatous pleural effusions of cancer patients. Cancer Immunol Immunother 1981; 11: 255–263.
   Google Scholar
• Monson JRT, Ramsden CW, Giles GR, Brennan TG, Guillon PJ. Lymphokine activated killer (LAK) cells in pa-tients with gastrointestinal cancer. Gut 1987; 28: 1420–1425.
   Google Scholar
• Shimizu Y, Iwatsuki S, Herberman RB, Whiteside TL. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors. Cancer Immunol Immunother 1991; 32: 280–288.
   Google Scholar
• Ioannides CG, Rashed S, Fisk B, Fan D, Itoh K, Freedman RS. Lymphocytes infiltrating ovarian malignant ascites: Modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8 + T cells by TNF-α. Lymphokine Cytokine Res 1991; 4: 307–315.
   Google Scholar
• Matossian-Rogers A, Brown C, Turkish M, O’Ryrne P, Festenstein H. Tumor necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells. Br J Cancer 1989; 59: 573–577.
   Google Scholar